| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | TANDEM DIABETES CARE INC COM | 20,000 | 24,000 | 0.00% | ||
| 2 | SEADRILL LIMITED | 20,000 | 33,000 | 0.00% | Call | |
| 3 | GERON CORP | 20,000 | 45,000 | 0.00% | ||
| 4 | CONATUS PHARMACEUTICALS INC | 11,500 | 66,000 | 0.00% | ||
| 5 | ONCONOVA THERAPEUTICS INC | 22,500 | 68,000 | 0.00% | ||
| 6 | AMICUS THERAPEUTICS INC COM | 10,000 | 71,000 | 0.00% | ||
| 7 | NOVADAQ TECHNOLOGIES INC | 10,000 | 78,000 | 0.00% | Call | |
| 8 | NAVIOS MARITIME PARTNERS L P | 38,650 | 80,000 | 0.00% | ||
| 9 | INFINITY PHARMACEUTICALS INC | 30,000 | 97,000 | 0.00% | ||
| 10 | ALIMERA SCIENCES INC | 85,000 | 119,000 | 0.00% | ||
| 11 | XENON PHARMACEUTICALS INC | 31,500 | 126,000 | 0.00% | ||
| 12 | CATALYST PHARMACEUTICALS INC | 68,000 | 133,000 | 0.01% | ||
| 13 | DIPLOMAT PHARMACY INC COM | 10,000 | 160,000 | 0.01% | ||
| 14 | OBALON THERAPEUTICS INC | 15,000 | 160,000 | 0.01% | ||
| 15 | EAGLE BULK SHIPPING INC | 30,142 | 172,000 | 0.01% | ||
| 16 | BARCLAYS BK PLC | 11,000 | 174,000 | 0.01% | ||
| 17 | TREVENA INC | 50,000 | 184,000 | 0.01% | ||
| 18 | RETROPHIN INC | 10,000 | 185,000 | 0.01% | ||
| 19 | DIGITAL TURBINE INC | 200,000 | 188,000 | 0.01% | ||
| 20 | PARATEK PHARMACEUTICALS INC | 10,000 | 193,000 | 0.01% | ||
| 21 | ADMA BIOLOGICS, INC. | 40,000 | 195,000 | 0.01% | ||
| 22 | SPDR S&P 500 ETF TR | 916 | 216,000 | 0.01% | ||
| 23 | RIGEL PHARMACEUTICAL INC | 70,000 | 232,000 | 0.01% | ||
| 24 | ABBOTT LABS | 5,232 | 232,000 | 0.01% | ||
| 25 | EXACT SCIENCES CORP | 10,000 | 236,000 | 0.01% | Call | |
| 26 | NOVARTIS A G | 3,500 | 260,000 | 0.01% | ||
| 27 | EARTHSTONE ENERGY INC | 22,247 | 284,000 | 0.01% | ||
| 28 | APPTIO INC | 25,000 | 293,000 | 0.01% | ||
| 29 | STAAR Surgical Co | 30,000 | 294,000 | 0.01% | ||
| 30 | ALTERYX INC | 20,000 | 313,000 | 0.01% | ||
| 31 | SEATTLE GENETICS INC | 5,000 | 314,000 | 0.01% | ||
| 32 | UNIQURE NV | 55,000 | 318,000 | 0.01% | ||
| 33 | DHT HOLDINGS INC | 72,000 | 322,000 | 0.01% | Call | |
| 34 | Aldeyra Therapeutics Inc | 65,000 | 325,000 | 0.01% | ||
| 35 | ADVAXIS INC COM NEW | 40,000 | 327,000 | 0.01% | ||
| 36 | PUMA BIOTECHNOLOGY | 9,000 | 335,000 | 0.01% | ||
| 37 | ULTRAGENYX PHARMACEUTICAL INC COM | 5,000 | 339,000 | 0.01% | Put | |
| 38 | IMMUNE DESIGN CORP | 50,000 | 340,000 | 0.01% | ||
| 39 | AGENUS INC | 91,000 | 343,000 | 0.01% | ||
| 40 | ARATANA THERAPEUTICS INC | 65,000 | 345,000 | 0.01% | ||
| 41 | Marchex Inc | 130,000 | 354,000 | 0.01% | ||
| 42 | SIGNET JEWELERS LIMITED | 5,163 | 358,000 | 0.01% | ||
| 43 | Curis, Inc | 130,000 | 361,000 | 0.01% | ||
| 44 | ENDOLOGIX INC | 50,000 | 362,000 | 0.01% | ||
| 45 | RAYMOND JAMES FINANC | 4,804 | 366,000 | 0.01% | ||
| 46 | GCP APPLIED TECHNOLOGIES INC | 11,315 | 369,000 | 0.01% | ||
| 47 | TA Associates Management LP | 44,000 | 370,000 | 0.01% | ||
| 48 | iRhythm Technologies, Inc. | 10,000 | 376,000 | 0.01% | ||
| 49 | FIRST HAWAIIAN INC COM | 12,800 | 383,000 | 0.02% | ||
| 50 | VOYA FINANCIAL INC | 10,260 | 389,000 | 0.02% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001062574-17-000006, filed 2017.05.15).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
